Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2S)-1-L-prolylpyrrolidine-2-carbonitrile | IC50: 2.9 nmol/L | Homo sapiens | |
(2S)-1-L-prolylpyrrolidine-2-carbonitrile | IC50: 2.9 nmol/L | Rattus norvegicus | |
3-((2S,4S)-4-anilino-2-pyrrolidinylcarbonyl)-1,3-thiazolidine | IC50: 147 nmol/L | Homo sapiens | |
3-((2S,4S)-4-anilino-2-pyrrolidinylcarbonyl)-1,3-thiazolidine | IC50: 190 nmol/L | Rattus norvegicus | |
3-L-prolyl-1,3-thiazolidine | IC50: 538 nmol/L | Homo sapiens | |
3-L-prolyl-1,3-thiazolidine | IC50: 607 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(2-chloro-4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 18.2 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(2-chloro-4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 21.8 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(2-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 24.1 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(2-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 41.3 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(3,4-dicyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 8.4 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(3,4-dicyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 10.8 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(3,4-methylenedioxyphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 29.0 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(3,4-methylenedioxyphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 34.5 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(3-chloro-4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 11.1nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(3-chloro-4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 13.0 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(3-chloro-4-methoxyphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 19.9 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(3-chloro-4-methoxyphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 14.8 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(4-aminophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 105 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(4-aminophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 125 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(4-chlorophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 45.4 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(4-chlorophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 55.1 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 25.2 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(4-cyanophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 33.6 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(4-methanesulfonylphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 52.3 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(4-methanesulfonylphenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 43.8 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(4-nitrophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 19.2 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(4-nitrophenyl)amino-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 21.0 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(5-cyano-2-pyridyl)amino-2-pyrolidinylcarbonyl]-1,3-thiazolidine | IC50: 25.4 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(5-cyano-2-pyridyl)amino-2-pyrolidinylcarbonyl]-1,3-thiazolidine | IC50: 30.4 nmol/L | Rattus norvegicus | |
3-[(2S,4S)-4-(p-anisidino)-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 51.5 nmol/L | Homo sapiens | |
3-[(2S,4S)-4-(p-anisidino)-2-pyrrolidinylcarbonyl]-1,3-thiazolidine | IC50: 54.9 nmol/L | Rattus norvegicus | |
6-([(3S,5S)-5-([(2S)-2-cyanopyrrolidin-1-yl]carbonyl)pyrrolidin-3-yl]amino)pyridine-3-carbonitrile | IC50: 0.25 nmol/L | Homo sapiens | |
6-([(3S,5S)-5-([(2S)-2-cyanopyrrolidin-1-yl]carbonyl)pyrrolidin-3-yl]amino)pyridine-3-carbonitrile | IC50: 0.27 nmol/L | Rattus norvegicus | |
6-([2-((2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl)amino)ethyl]amino)pyridine-3-carbonitrile | IC50: 1.4 nmol/L | Homo sapiens | |
6-([2-((2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl)amino)ethyl]amino)pyridine-3-carbonitrile | IC50: 2.3 nmol/L | Rattus norvegicus | |
6-[(2-([2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]amino)ethyl)amino]pyridine-3-carbonitrile | IC50: 270 nmol/L | Homo sapiens | |
6-[(2-([2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]amino)ethyl)amino]pyridine-3-carbonitrile | IC50: 500 nmol/L | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood plasma | - |
Homo sapiens | - |
blood plasma | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Gly-Pro-4-methylcoumarin 7-amide + H2O | - |
Homo sapiens | Gly-Pro + 7-amino-4-methylcoumarin | - |
? | |
Gly-Pro-4-methylcoumarin 7-amide + H2O | - |
Rattus norvegicus | Gly-Pro + 7-amino-4-methylcoumarin | - |
? |